Structural rearrangements of the genome can drive lung tumorigenesis through the generation of fusion genes with oncogenic properties. Advanced genomic approaches have identified the presence of a genetic fusion between fibroblast growth factor receptor 3 (FGFR3) and transforming acidic coiled-coil 3 (TACC3) in non-small cell lung cancer (NSCLC), providing a novel target for FGFR inhibition. To interrogate the functional consequences of the FGFR3-TACC3 fusion in the transformation of lung epithelial cells, we generated a novel transgenic mouse model that expresses FGFR3-TACC3 concomitant with loss of the p53 tumor suppressor gene. Intranasal delivery of an Ad5-CMV-Cre virus promoted seromucinous glandular transformation of olfactory cells lining the nasal cavities of FGFR3-TACC3 (LSL-F3T3) mice, which was further accelerated upon loss of p53 (LSL-F3T3/p53). Surprisingly, lung tumors failed to develop in intranasally infected LSL-F3T3 and LSL-F3T3/p53 mice. In line with these observations, we demonstrated that intranasal delivery of Ad5-CMV-Cre induces widespread Cre-mediated recombination in the olfactory epithelium. Intra-tracheal delivery of Ad5-CMV-Cre into the lungs of LSL-F3T3 and LSL-F3T3/p53 mice, however, resulted in the development of lung adenocarcinomas. Taken together, these findings provide in vivo evidence for an oncogenic function of FGFR3-TACC3 in respiratory epithelium.
Introduction
Lung cancer represents the most common malignancy worldwide, and the leading cause of cancer-related death [1] . Next-generation sequencing technologies have provided an in-depth characterization of small cell lung cancer (SCLC) [2] and non-small cell lung cancer (NSCLC) subtypes, including adenocarcinoma (ADC) [3] and squamous cell carcinoma (SCC) [4] . Combined, these studies have highlighted the highly complex genomic landscape of lung cancer, represented by high rates of somatic alterations, copy number changes, and genomic rearrangements [5] . Structural genomic rearrangements can lead to the development of fusion genes with oncogenic properties. In the respiratory system, the best characterized of these is the EML4-ALK gene fusion, which is detected in 1-5% of ADC [6] . Characterization of the EML4-ALK fusion gene has led to more successful targeted treatments for these gene rearrangement patients [7] .
The FGFR3-TACC3 fusion gene has been described in 3-4% of lung SCC [8, 9] and also in nasopharyngeal carcinoma (NPC) [10] , glioblastoma [11] , cervical cancer [12] , and bladder cancer [5, 13] . The chromosomal translocation between fibroblast growth factor receptor 3 (FGFR3) and transforming acidic coiled-coiled 3 (TACC3) generates a fusion of the tyrosine kinase domain of FGFR3, upstream of the coiled-coil domain of TACC3, however the exact position of the breakpoint is variable between patients [8, 11, 12, 14] . The transforming activity of FGFR3-TACC3 has been suggested to result from alterations in canonical signaling activity [13] , loss of microRNA regulation [15] , or from loss of maintenance of the mitotic spindle [11] . However, the oncogenic potential of the FGFR3-TACC3 fusion in lung epithelium has not yet been assessed in vivo.
Genetically engineered mouse models (GEMMs) of human lung cancer genomic alterations are a powerful in vivo platform to dissect molecular mechanisms underlying tumor initiation and progression [16] . Moreover, mouse models that use strategic gene targeting to both amplify and accelerate candidate pathogenic mechanisms have an especially high utility because they allow drug sensitivity and resistance studies to be performed in a timely, systematic, and definitive manner [17] . This is exemplified in mouse models of EML4-ALK, where therapeutic response mimicked that observed in human patients [18, 19] . FGFR signaling is implicated in the etiology of lung pathogenesis, and to date several GEMMs have been generated based on Cre-inducible expression of a mutant active form of FGFR1 (K656E) [20] and FGFR9 [21] . However, to date, no GEMMs of FGFR3-TACC3 exist, representing a significant gap in our ability to mechanistically understand treatments to combat this subset of lung cancer patients.
To interrogate the functional significance of the FGFR3-TACC3 gene fusion in lung tumorigenesis, we generated a novel GEMM driven by the Cre-inducible expression of the FGFR3-TACC3 fusion oncoprotein. Expression of FGFR3-TACC3 (F3T3) was activated in the respiratory tract through intranasal inhalation of adenovirus-Cre, mediating recombination in both lung epithelium [22] and olfactory and respiratory epithelia of the nasal cavity [23] .
Strikingly, in contrast to lung epithelium, the nasal olfactory epithelium was exquisitely sensitive to the oncogenic effects of F3T3. Tumorigenesis was accelerated by additional loss of p53 with a median survival of 6 months for LSL-F3T3/ p53 mice due to obstruction of the nasal airway. Intratracheal administration of recombinant Ad5-Cre viruses effectively bypassed the nasal cavity, allowing lung tumors to develop. FGFR3-TACC3 promoted the transformation of respiratory cells through augmentation of the mitogenactivated protein kinase (MAPK) pathway characterized by elevated levels of phosphorylated-ERK1/2 but did not affect phosphoinositide 3-kinase (PI3K) pathway activity. Taken together, these findings indicate that the FGFR3-TACC3 fusion protein acts as an oncogene in the respiratory tract.
Results and discussion

FGFR3-TACC3 is an oncogenic fusion protein in human lung NSCLC cells
To determine whether FGFR3-TACC3 acts as an oncogenic fusion protein in NSCLC, we stably expressed the human fusion protein FGFR3-TACC3 (FGFR3 exon 18-TACC3 exon 10) [9] (hereafter, F3T3) in H2170 cells ( Fig. 1a ). H2170 cells are a human lung SCC cell line expressing normal FGFR1 copy number [24] . Colony formation assays were performed using H2170 stable cell lines to investigate whether the F3T3 fusion protein can enhance the transformation capacity of lung SCC cells. As shown in Fig. 1b , F3T3-expressing H2170 cells formed significantly more colonies compared to the empty vector control cells. Quantification of crystal violet staining confirmed these observations (p < 0.01; Fig. 1c ). Taken together, these results suggest that F3T3 acts as a chimeric oncogene in lung SCC.
Generation of LSL-FGFR3-TACC3 conditional mice
To directly assess the effects of FGFR3-TACC3 fusion expression in the respiratory system, we engineered a novel mouse model harboring the human FGFR3-TACC3 fusion cDNA. The transgene cassette was inserted into the Col1A locus, with temporal expression achieved utilizing the control of lox-stop-lox (LSL) recombination under a strong CAGGs promoter ( Fig. 1d ), an approach that allows for robust transgene expression [25] . To validate a successful recombination event, targeted embryonic stem (ES) cell clones were infected with Ad5-CMV-Cre and protein lysates were prepared 48 h following infection. Western blot analysis using an antibody that recognizes the intact FGFR3 portion of the fusion protein, confirmed restricted expression of the FGFR3-TACC3 fusion protein in ES cell clones following Ad5-CMV-Cre infection. No expression was detected in uninfected clones (Supplementary Figure  1a) , validating that the LSL system is not leaky. To rule out the possibility of rearrangement of the locus in vivo, mouse embryonic fibroblasts (MEFs) were isolated from embryonic day (E) 14.5 LSL-FGFR3-TACC3 embryos. Human FGFR3 protein expression was detected in F3T3 transgenic MEFs analyzed 72 h following infection with an Ad5-CMV-Cre virus (Fig. 1e ). No expression of FGFR3 was detected in uninfected LSL-F3T3 MEFs (Fig. 1e ), confirming stable expression of the transgene in vivo. Next, to validate recombination in cells of the respiratory tract, tracheal epithelial cells were isolated from LSL-F3T3 adult mice according to established protocols [26] and infected in vitro with Ad5-CMV-Cre ( Supplementary Figure 1b) . Figure 1a ) and MEFs ( Fig. 1c ), expression of the FGFR3-TACC3 fusion protein was restricted to Crerecombined LSL-F3T3 tracheal epithelial cells (Supplementary Figure 1c ).
Consistent with our findings in ES cells (Supplementary
The FGFR3-TACC3 fusion is highly oncogenic in nasal olfactory epithelium
To confirm that FGFR3-TACC3 acts as an oncogenic fusion protein in lung epithelium, LSL-F3T3 mice were intranasally (i.n.) infected with an Ad5-CMV-Cre virus. Given that TP53 mutations occur in >90% of human lung SCC [4] and 46% lung ADC [3] , LSL-F3T3 mice were also crossed with p53 f/f mice [27] (hereafter, LSL-F3T3/p53). Tumor initiation and progression was monitored at defined time points (3, 6, and 9 months) post Ad5-CMV-Cre infection or analyzed when LSL-F3T3 and LSL-F3T3/p53 mice displayed signs of morbidity (breathing difficulties, weight loss) ( Fig. 2a ). Consistent with observations made in glioblastoma [11] , enforced expression of FGFR3-TACC3 in combination with p53 loss reduced the survival latency of LSL-F3T3 mice (undefined vs. 188 days; p < 0.0001) ( Fig. 2b) . Surprisingly, histological analysis of lung tissue from LSL-F3T3 and LSL-F3T3/p53 Ad5-CMV-Cre-infected mice revealed the complete absence of epithelial hyperplasia and gross tumor formation ( Fig. 2c and Supplementary Table 1 ). Interestingly, however, extensive seromucinous (glandular) hyperplasia of epithelial cells lining the posterior nasopharynx was observed in both LSL-F3T3 and LSL-F3T3/p53 mice ( Fig.  2c and Supplementary Table 1 ), and was already apparent in LSL-F3T3/p53 mice, 3 months following intranasal Ad5-CMV-Cre infection ( Supplementary Table 1 and Supplementary Figure 2 ). Therefore, given that mice are obligate nose breathers [28] , the cause of mortality in LSL-F3T3/p53 mice was confirmed to be restricted airway capacity in the nasal cavity. Western blot analysis of FGFR3 (Santa Cruz, Dallas, TX, USA; sc-13121, 1:700) in parental, vector, and FGFR3-TACC3-expressing H2170 cells. β-actin (Sigma-Aldrich, Saint Louis, MO, USA; A5441, 1:1000) served as a loading control. H2170 cells (ATCC, Manassas, VA, USA; CRL-5928) were maintained in RPMI 1640 supplemented with 10% fetal calf serum, 100 units/ml penicillin and 100 μg/ml streptomycin (Life Technologies, Carlsbad, CA, USA). cDNA encoding the human FGFR3-TACC3 fusion (exon 18-exon 10) was PCR amplified from FGFR3-TACC3 pCDH510B, a kind gift from Dr Chinnaiyan [9] , using primers; 5′-GCGGTCGACGCCACCATGGGCGCC-3′ and 5′-GCGA-GAATTCTCAGATCTTCTCCATCTTGGA-3′, and sub-cloned into the pMSCV-GFP retrovirus. To generate retroviral particles, pMSCV-FGFR3-TACC3 or pMSCV-GFP were transfected into 293T cells with calcium chloride, together with the packaging plasmids gag-pol and VSV. Culture supernatants were harvested after 32 and 48 h, filtered through a 0.45 μm filter and used to transduce H2170 cells with 1 μg/ml polybrene. Forty-eight hours post transduction, GFP + -transduced cells were sorted on the BD FACS Aria (BD Biosciences), before replating for in vitro analysis. Western blot analysis was performed according to standard procedures. b Representative images of crystal violet-stained colony assays of vector and F3T3 H2170 cells. Scale, 5 mm. Cells were plated in 12-well plates at a density of 10,000 cells/well. After 72 h, cells were fixed with 1:1 ice-cold acetone/methanol for 1 min and incubated with 0.1% crystal violet for 20 min. Wells were imaged with Zeiss Stemi 2000-C using Zen software (Zeiss). c Quantification of colony assays were performed as described [54] . Mean ± SEM. p < 0.01. d Schematic representation of the Col1a1 locus targeted with the LSL-FGFR3-TACC3 transgene before and following Cre-mediated recombination. cDNA encoding the human FGFR3-TACC3 fusion (exon 18-exon 10) [9] was PCR amplified using primers; 5′-GCGGGCGCGCCAC-CATGGGCGCCCCTGCCTGC-3′ and 5′-GCGATCTAGATCA-GATCTTCTCCATCTTGGA-3′, and sub-cloned into the pCAGGS-LSL vector and KH2 ES cells were targeted as previously described [55] . e Western blot of FGFR3 (Santa Cruz, Dallas, TX, USA; sc-13121, 1:700) protein in mouse embryonic fibroblasts (MEFs) generated from wild-type (WT) and LSL-FGFR3-TACC3 (LSL-F3T3) E14.5 embryos, 72 h following Ad5-CMV-Cre infection (+). Uninfected (−) cells served as a control, while GAPDH (Sigma-Aldrich, Saint Louis, MO, USA; G8795, 1:5000) provides the loading control. MEFs were generated as previously described [56] Fig. 2 FGFR3-TACC3 fusion protein is a potent oncogene in nasal epithelium. a Schematic outline of experimental strategy. Animal experiments were conducted according to the regulatory standards approved by the Walter and Eliza Hall Animal Ethics Committee (AEC 2016.024). p53 f/f mice were obtained from Jackson Laboratories and genotyped as previously described [27] . LSL-F3T3 mice were genotyped using primers: 5′-CCAGTTCAATCATCCCAGGT-3′, 5′-GGCCATCGGAATAGGAACTT-3′, and 5′-CAACCTGGTCCTC-CATGTCT-3′, according to standard procedures. Seven-to eightweek-old conditional mice were intranasally (i.n.) infected with 20 μl of 1 × 10 10 PFU/ml Ad5-CMV-Cre virus (University of Iowa Gene Transfer Core Facility) according to standard procedures [22] . Lungs and nasal cavities were harvested at defined time points following Ad5-CMV-Cre administration, or when mice showed signs of morbidity (breathing difficulties and weight loss) for Kaplan-Meier analysis. b Kaplan-Meier survival analysis of LSL-F3T3 (n = 17) and LSL-F3T3/p53 (n = 5) mice following i.n. of Ad5-CMV-Cre virus. ****p < 0.0001. Kaplan-Meier analysis was performed using the Mantel-Cox test. c Representative hematoxylin and eosin (H&E)stained sections of the nasal cavities and lungs LSL-F3T3 and LSL-F3T3/p53 mice analyzed 12 and 6 months, respectively, following Ad5-CMV-Cre infection. Scale, low power: 1 mm; high power: 100 μm. Lungs were perfused and fixed with 4% paraformaldehyde for 24 h at 4°C and embedded in paraffin. Nasal cavities were fixed in 4% paraformaldehyde for 24 h at 4°C, de-calcified using Fast-Cal and paraffin embedded. Sections 2 μm thick were stained with H&E. d Representative immunohistochemistry of FGFR3 (Santa Cruz, Dallas, TX, USA; sc-13121, 1:100), Ki67 (Cell Signaling, Beverly, MA, USA; #12202, 1:400), p-ERK1/2 (Cell Signaling, Beverly, MA, USA; #9101, 1:200) and p-AKT (Cell Signaling, Beverly, MA, USA; #4060, 1:200) in hyperplastic nasal epithelium of LSL-F3T3/p53 mice, analyzed 6 months following Ad5-CMV-Cre infection. Inset, isotype control. Scale, 100 μm. Immunohistochemistry was performed as described [57] FGFR3-TACC3 is an oncogenic fusion protein in respiratory epithelium To confirm that the nasal olfactory hyperplasia observed resulted from enforced expression of F3T3, lesions were immunostained using an FGFR3 antibody. As expected, high FGFR3 expression was specifically detected in hyperplastic cells (Fig. 2d) , with no expression observed in adjacent normal epithelium (data not shown). Moreover, hyperplastic F3T3-expressing cells stained positive for Ki67 ( Fig. 2d) , indicating that the lesions are highly proliferative. Given that canonical FGFR3 kinase activity signals through the MAPK and PI3K pathways [29, 30] , we investigated the activity of these signaling pathways in hyperplastic nasal epithelium. Hyperplastic lesions detected in LSL-F3T3/p53 and LSL-F3T3 nasal cavities exhibited strong, albeit heterogeneous pERK1/2 staining, while pAKT staining was uniformly weak (Fig. 2d ; data not shown). Thus, consistent with previous reports in human cancer cells [15, 31, 32] , the oncogenic capacity of the FGFR3-TACC3 fusion is mediated through the enhanced activity of the MAPK signaling pathway.
The exquisite sensitivity of olfactory epithelial cells to enforced expression of F3T3 is consistent with the identification of the FGFR3-TACC3 gene fusion in 2.5% of NPCs [10] . Indeed, NPC cell lines engineered to overexpress FGFR3-TACC3 were found to display growthpromoting qualities, most likely through the functionality of the FGFR3 kinase portion of the fusion protein [10] . The relationship between the hyperplasia observed in LSL-F3T3 and LSL-F3T3/p53 mice and NPC remains unclear, as mice succumb to breathing difficulties before advanced disease develops.
Intranasal adenovirus infection results in widespread nasal epithelial cell infection
To gain greater insight into the efficiency and repertoire of cell types infected in the nasal cavity following intranasal delivery of Ad5-Cre viruses, we utilized the mT/mG reporter mouse strain [33] . In mT/mG mice, all cells express membrane-bound Tomato (mT) prior to Cre-recombination and are induced to express membrane-bound GFP (mG) upon Cre-mediated excision. To investigate the presence of Cre-infected cells in both the proximal and distal nasal cavity [34] , mT/mG mice were intranasally infected with either a ubiquitous Ad5-CMV-Cre virus or Ad5-CC10-Cre virus, with the latter targeting Cre-recombinase expression specifically to club cells lining the large and small airways of the mouse lung [35] . Immunostaining performed on nasal cavity tissue harvested 2 weeks following infection revealed extensive sporadic GFP expression in the nasal cavities of Ad5-CMV-Cre-infected mT/mG mice (Fig. 3a) . Conversely, no GFP-positive cells were detected in the nasal cavities of Ad5-CC10-Cre-infected and mT/mG uninfected control mice (Fig. 3a) .
The olfactory sensory epithelium is composed of three major cell types: neurons, supporting cells, and basal stem cells, responsible for generating olfactory neurons throughout life [36] (Fig. 3b) . To determine which of these cell types are most susceptible to Ad5-CMV-Cre infection, we performed fluorescence co-staining for GFP together with Sox2, a marker of supporting cells [37] . GFP-positive "switched" cells had long projections that spanned the sensory neuron layer, with cell bodies overlapping with Sox2 staining (Fig. 3c) , indicating that Cre is specifically activated in supporting cells. It has been observed, and we clearly demonstrate, that intranasal inhalation of adenovirus infects the olfactory and respiratory epithelium [23, [38] [39] [40] , although the degree of infection and potential functional consequences associated have been far less documented. Interestingly, the incidence of sinonasal adenocarcinomas observed in K-ras LSL-G12D/+ /p53 f/f mice following intranasal delivery of Ad5-CMV-Cre was significantly potentiated when oncogenic activation of Kras G12D was combined with expression of mutant p53 (p53 R270H or p53 R175H ) [41] . Moreover, tumors exhibiting a squamous phenotype were observed in the nasal cavities of mice engineered to overexpress Sox2 in combination with Pten and Cdkn2ab inactivation, following administration of an adenovirus expressing Cre-recombinase under the control of the keratin 5 (K5) gene promoter [20] . Thus, together with results from this study, we would argue that caution should be taken in the design of new conditional mouse models for lung tumor studies, to avoid the preferential transformation of epithelial cells lining the nasal cavity.
FGFR3-TACC3 expression promotes tumorigenesis in lung epithelium
We hypothesized that the presence of hyperplasia in the nasal cavities of LSL-F3T3 and LSL-F3T3/p53 mice at early time points following intranasal delivery of Ad5-CMV-Cre, may restrict the time required for lung tumor formation. Thus, to bypass the infection of nasal epithelium, we delivered the Ad5-CMV-Cre virus via intra-tracheal instillation, a procedure routinely used to generate autochthonous lung tumors in genetically modified mice [35, 42, 43] . First, we needed to confirm that intra-tracheal administration of Ad5-CMV-Cre would bypass the infection of nasal epithelium observed following intranasal delivery of Cre-recombinase. To directly address this question, mT/mG mice were intra-tracheally infected with Ad5-CMV-Cre virus, and nasal cavities and lung tissue were harvested 2 weeks following infection. In contrast to the GFP-staining pattern observed following intranasal infection (Fig. 3a) , intra-tracheal delivery of Ad5-CMV-Cre dramatically reduced the number of GFP-positive cells in the olfactory epithelium ( Supplementary Figure 3a) . The presence of GFP-positive "switched" cells lining the bronchiolar and alveolar airways of the lung validated the efficiency of the intra-tracheal procedure ( Supplementary Figure 3a) .
Consistent with a significant reduction in the infection of nasal epithelium, the presence of seromucinous hyperplasia was less frequently observed in LSL-F3T3 and LSL-F3T3/ p53 mice analyzed 12 months following intra-tracheal Ad5-CMV-Cre infection ( Supplementary Table 1 ). Moreover, the degree of hyperplasia was also less pronounced (Supplementary Figure 3b ) enabling LSL-F3T3/p53 mice to survive past 7 months. Interestingly, focal lung tumors were observed in the lungs of 2/13 LSL-F3T3 mice, which further increased in penetrance following the additional loss of p53 ( Fig. 4a and Supplementary Table 1 ). The tumors detected in LSL-F3T3 mice were classified as adenocarcinomas, with tumors exhibiting a homogeneous papillary-like morphology and displaying high expression levels of Nkx2.1/TTF-1, a clinical marker of adenocarcinomas ( Supplementary Figure 3c) . Moreover, the tumors co-expressed FGFR3, confirming that these tumors were driven by expression of the FGFR3-TACC3 transgene ( Supplementary Figure 3c) . In comparison, the lung tumors that developed in 4/8 of LSL-F3T3/p53 mice displayed two distinct pathologic characteristics ( Fig. 4a-b ). One subset of tumors displayed a well-differentiated papillary growth pattern expressing high levels of Nkx2.1 (Fig. 4b, left panel  A) , while the remaining tumors showed signs of mixed lipidic, acinar, and papillary growth (Fig. 4b, right panel B) . Lipidic pattern lesions (Type B) displayed an abundance of neutral-mucin PAS-positive cells, reduced Nkx2.1 Fig. 3 Adenovirus-mediated Cre delivery effectively infects nasal epithelium. a Representative immunostaining of GFP (Abcam, Cambridge, UK; ab6556, 1:200 [20] ) in the nasal cavity of mT/mG reporter mice 2 weeks following i.n. infection of Ad5-CMV-Cre (n = 3) or Ad5-CC10-Cre (n = 3) adenoviruses. Uninfected mT/ mG mice (n = 3) served as controls. Scale, 100 μm. b Schematic representation of the olfactory epithelium (adapted from ref. [37] ). c Immunofluorescence costaining of GFP and Sox2 (Santa Cruz, Santa Cruz, CA, USA; sc-17320, 1:1000) in the olfactory epithelium of mT/mG mice 2 weeks following Ad5-CMV-Cre infection. Scale, 100 μm. For immunofluorescence, fluorescently labeled secondary antibodies (Thermo Scientific) were incubated with 1 μg/ml DAPI (Sigma-Aldrich, Saint Louis, MO, USA; D9542) in the dark for 1 h at room temperature. After washing, slides were mounted in Fluoromount-G (Southern Biotech, Chicago, IL, USA; 0100-01), cover-slipped and imaged on the Zeiss AxioObserver microscope using Zen software (Zeiss) expression, and sporadic regions expressing the squamous markers p63 and Sox2 ( Fig. 4b and Supplementary Figure  4a, right panel B) . The mucinous transdifferentiation, however, appears not to be driven by transcription factor HNF4α expression [44] (Supplementary Figure 4a, b) .
Consistent with observations made in the nasal cavity ( Fig.  2d ), overexpression of FGFR3 correlated with increased MAPK, but not PI3K signaling in both tumor subsets ( Fig.  4b ). While these findings confirm that enforced expression of the FGFR3-TACC3 fusion in vivo can promote the transformation of lung epithelium, its capacity as an oncogenic driver is weaker than what is observed with other lung cancer gene fusions, such as EML4-ALK [18, 19] .
Although the FGFR3-TACC3 fusion is also observed in lung SCC [8, 9] , the lung tumors that developed in LSL-F3T3 and LSL-F3T3/p53 mice were classified as lung adenocarcinomas (Fig. 4a ). To determine whether F3T3 gene fusions are also found in human lung ADC, we interrogated publicly available cancer data sets including TCGA [3] and MSK-IMPACT [45, 46] , accessed via cBioPortal [47, 48] . While no fusion events were identified in the TCGA dataset consistent with a recent report [5] , five lung ADC patients harboring F3T3 gene fusions were identified in the MSK-IMPACT clinical sequencing cohort [45, 46] . Critically, this analysis revealed the presence of F3T3 gene fusions in lung ADC, consist with our findings and highlighting the clinical relevance of our GEMM.
Interestingly, markers of squamous cell differentiation, Sox2 and p63, were observed in a subset of ADC cells, suggesting that additional genetic events, such as Sox2 overexpression, may be required to drive a fully penetrant squamous cell phenotype [20, 49] . Moreover, we cannot rule out that directing F3T3 expression to lung basal progenitor cells may also promote the formation of lung SCC tumors, given that basal cells are the putative cell of origin of lung SCC [20, 50, 51] . Interestingly, perturbations in PI3K pathway components are more prevalent in lung SCC [52] , where Pten inactivation has been shown to play an important role in driving lung SCC formation characterized by elevated p-AKT activity [53] . The preferential activation of the MAPK signal transduction pathway downstream of F3T3 may have therefore influenced the formation of lung ADC over lung SCC. Interestingly, expression of the F3T3 oncoprotein in head and neck squamous cell carcinoma cells was recently shown to be responsible for acquired resistance to combined blockade of EGFR/ERBB3 therapies by reactivating MAPK signaling [32] . Together, our Fig. 4 Intra-tracheal-mediated adenovirus-Cre delivery enables lung tumor formation. a Representative H&E-stained sections of LSL-F3T3 and LSL-F3T3/p53 12 months following intra-tracheal (i.t.) delivery of Ad5-CMV-Cre. Briefly, 7-8-week-old conditional mice were infected (i.t.) with 20 μl of 1 × 10 10 PFU/ml Ad5-CMV-Cre virus (University of Iowa Gene Transfer Core Facility) as described [58] . A represents Type A lesion, box B represents a Type B lesion. Scale, 100 μm. b Representative H&E and immunostaining of Nkx2.1 (TTF-1; DAKO, Santa Clara, CA, USA; #M3575, 1:200), PAS/Alcian Blue (PAS/AB), FGFR3, p-ERK1/2, p-AKT on Type A and Type B lung tumors from LSL-F3T3/p53 mice, 12 months following intra-tracheal Ad5-CMV-Cre infection. Scale, 100 μm findings highlight the importance of our novel transgenic model as a tool to better understand the behavior of the F3T3 fusion and how it could be therapeutically exploited in the clinic.
